Geographical variation in Plasmodium vivax relapse
- PMID: 24731298
- PMCID: PMC4021508
- DOI: 10.1186/1475-2875-13-144
Geographical variation in Plasmodium vivax relapse
Abstract
Background: Plasmodium vivax has the widest geographic distribution of the human malaria parasites and nearly 2.5 billion people live at risk of infection. The control of P. vivax in individuals and populations is complicated by its ability to relapse weeks to months after initial infection. Strains of P. vivax from different geographical areas are thought to exhibit varied relapse timings. In tropical regions strains relapse quickly (three to six weeks), whereas those in temperate regions do so more slowly (six to twelve months), but no comprehensive assessment of evidence has been conducted. Here observed patterns of relapse periodicity are used to generate predictions of relapse incidence within geographic regions representative of varying parasite transmission.
Methods: A global review of reports of P. vivax relapse in patients not treated with a radical cure was conducted. Records of time to first P. vivax relapse were positioned by geographic origin relative to expert opinion regions of relapse behaviour and epidemiological zones. Mixed-effects meta-analysis was conducted to determine which geographic classification best described the data, such that a description of the pattern of relapse periodicity within each region could be described. Model outputs of incidence and mean time to relapse were mapped to illustrate the global variation in relapse.
Results: Differences in relapse periodicity were best described by a historical geographic classification system used to describe malaria transmission zones based on areas sharing zoological and ecological features. Maps of incidence and time to relapse showed high relapse frequency to be predominant in tropical regions and prolonged relapse in temperate areas.
Conclusions: The results indicate that relapse periodicity varies systematically by geographic region and are categorized by nine global regions characterized by similar malaria transmission dynamics. This indicates that relapse may be an adaptation evolved to exploit seasonal changes in vector survival and therefore optimize transmission. Geographic patterns in P. vivax relapse are important to clinicians treating individual infections, epidemiologists trying to infer P. vivax burden, and public health officials trying to control and eliminate the disease in human populations.
Figures
Similar articles
-
Quantifying effect of geographic location on epidemiology of Plasmodium vivax malaria.Emerg Infect Dis. 2013 Jul;19(7):1058-65. doi: 10.3201/eid1907.121674. Emerg Infect Dis. 2013. PMID: 23763820 Free PMC article.
-
Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria.Proc Biol Sci. 2016 Mar 30;283(1827):20160048. doi: 10.1098/rspb.2016.0048. Proc Biol Sci. 2016. PMID: 27030414 Free PMC article.
-
Defining the relationship between Plasmodium vivax parasite rate and clinical disease.Malar J. 2015 May 7;14:191. doi: 10.1186/s12936-015-0706-3. Malar J. 2015. PMID: 25948111 Free PMC article.
-
Determinants of relapse periodicity in Plasmodium vivax malaria.Malar J. 2011 Oct 11;10:297. doi: 10.1186/1475-2875-10-297. Malar J. 2011. PMID: 21989376 Free PMC article. Review.
-
Relapse.Adv Parasitol. 2012;80:113-50. doi: 10.1016/B978-0-12-397900-1.00002-5. Adv Parasitol. 2012. PMID: 23199487 Review.
Cited by
-
Molecular identification of vivax malaria relapse patients in the Yunnan Province based on homology analysis of the Plasmodium vivax circumsporozoite protein gene.Parasitol Res. 2023 Jan;122(1):85-96. doi: 10.1007/s00436-022-07700-7. Epub 2022 Nov 5. Parasitol Res. 2023. PMID: 36334150 Free PMC article.
-
Primaquine treatment and relapse in Plasmodium vivax malaria.Pathog Glob Health. 2016;110(1):1-8. doi: 10.1080/20477724.2015.1133033. Epub 2016 Feb 18. Pathog Glob Health. 2016. PMID: 27077309 Free PMC article. Review.
-
Parasite-Host Interaction and Pathophysiology Studies of the Human Relapsing Malarias Plasmodium vivax and Plasmodium ovale Infections in Non-Human Primates.Front Cell Infect Microbiol. 2021 Feb 17;10:614122. doi: 10.3389/fcimb.2020.614122. eCollection 2020. Front Cell Infect Microbiol. 2021. PMID: 33680982 Free PMC article. Review.
-
Characterization of Plasmodium vivax-associated admissions to reference hospitals in Brazil and India.BMC Med. 2015 Mar 20;13:57. doi: 10.1186/s12916-015-0302-y. BMC Med. 2015. PMID: 25889040 Free PMC article.
-
Mass Relapse Prevention to Reduce Transmission of Plasmodium vivax- A Systematic Review.Am J Trop Med Hyg. 2023 Dec 20;110(4_Suppl):38-43. doi: 10.4269/ajtmh.22-0727. Print 2024 Apr 2. Am J Trop Med Hyg. 2023. PMID: 38118171 Free PMC article.
References
-
- Gething PW, Elyazar IRF, Moyes CM, Smith DL, Battle KE, Guerra CA, Patil AP, Tatem AJ, Howes RE, Myers MF, George DB, Horby P, Wertheim HFL, Price RN, Mueller I, Baird JK, Hay SI. A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis. 2012;6:e1814. doi: 10.1371/journal.pntd.0001814. - DOI - PMC - PubMed
-
- Battle KE, Gething PW, Elyazar IR, Moyes CL, Sinka ME, Howes RE, Guerra CA, Price RN, Baird KJ, Hay SI. The global public health significance of Plasmodium vivax. Adv Parasitol. 2012;80:1–111. - PubMed
-
- Barcus MJ, Basri H, Picarima H, Manyakori C, Sekartuti, Elyazar I, Bangs MJ, Maguire JD, Baird JK. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am J Trop Med Hyg. 2007;77:984–991. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
